Bibliographie (2546)
Opinion | Protective immunity after recovery from SARS-CoV-2 infection.
mercredi, 10 novembre 2021 09:16 Écrit par Zouhair SouissiProtective immunity after recovery from SARS-CoV-2 infection – The Lancet Infectious Diseases Commentary on Twitter "Policy makers should consider recovery from previous SARS-CoV-2 infection equal to immunity from vaccination for purposes related to entry to public events, businesses, and the workplace,or travel requirements" Do you agree with this?I don't #IDtwitter https://t.co/FHbgXILD8Z — Antibiotic Stewa®️x? […]
The post Opinion | Protective immunity after recovery from SARS-CoV-2 infection. appeared first on Links Medicus.
A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm.
mercredi, 10 novembre 2021 09:16 Écrit par Zouhair SouissiA prominent virologist warns COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm – Science Original viewpoint: Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1) – Forbes Related: The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first. Merck to allow other nations to produce new COVID-19 antiviral. […]
The post A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm. appeared first on Links Medicus.
![[Preprint] RCT: In hypoxic but not critically ill patients with COVID-19, an intervention to increase prone positioning did not improve outcomes.](/media/k2/items/cache/8adaab906335a500d629a55f4f3ed11a_M.jpg)
[Preprint] RCT: In hypoxic but not critically ill patients with COVID-19, an intervention to increase prone positioning did not improve outcomes.
mercredi, 10 novembre 2021 09:16 Écrit par Zouhair SouissiRCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv Related: RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19. RCT: Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19 – no difference in intubation rates compared to standard care. M-A: Prone positioning of nonintubated […]
The post [Preprint] RCT: In hypoxic but not critically ill patients with COVID-19, an intervention to increase prone positioning did not improve outcomes. appeared first on Links Medicus.
Review: Antineutrophil cytoplasmic antibody-associated interstitial lung disease.
mercredi, 10 novembre 2021 08:13 Écrit par Zouhair SouissiAntineutrophil cytoplasmic antibody-associated interstitial lung disease: a review – European Respiratory Review
The post Review: Antineutrophil cytoplasmic antibody-associated interstitial lung disease. appeared first on Links Medicus.
Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.
mardi, 09 novembre 2021 02:53 Écrit par Zouhair SouissiAssociation of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic – JAMA Internal Medicine Author Interview: Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms – JAMA Internal Medicine Commentaries: Expert reaction to study looking at the association of self-reported […]
The post Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection. appeared first on Links Medicus.
Practice Review: COVID-19 rapid diagnostics.
mardi, 09 novembre 2021 02:53 Écrit par Zouhair SouissiCOVID-19 rapid diagnostics: practice review – Emergency Medicine Journal
The post Practice Review: COVID-19 rapid diagnostics. appeared first on Links Medicus.
![[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.](/media/k2/items/cache/4f7ef1c9de3583543c3077db338910bc_S.jpg)
[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.
dimanche, 07 novembre 2021 21:37 Écrit par Zouhair SouissiPfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR Study Commentaries: Expert reaction to press release from Pfizer giving interim analysis of their Phase 2/3 EPIC-HR study of PAXLOVID™ in non-hospitalized high-risk adults with COVID-19 – Science Media Centre Pfizer’s Good News […]
The post [Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. appeared first on Links Medicus.
COVID-19 vaccination in pregnancy, pediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety.
dimanche, 07 novembre 2021 21:37 Écrit par Zouhair SouissiCOVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety – Drug Safety
The post COVID-19 vaccination in pregnancy, pediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety. appeared first on Links Medicus.
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
vendredi, 05 novembre 2021 13:23 Écrit par Zouhair SouissiThe U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first – NPR Related: Merck to allow other nations to produce new COVID-19 antiviral. Video: Merck’s Covid pill could transform treatment. Here’s how it works. How antiviral pill Molnupiravir shot ahead in the COVID drug hunt. What we know — and don’t know — […]
The post The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first. appeared first on Links Medicus.
Review: SARS-CoV-2 indoor air transmission is a threat that can be addressed with science.
vendredi, 05 novembre 2021 13:23 Écrit par Zouhair SouissiSARS-CoV-2 indoor air transmission is a threat that can be addressed with science – Proceedings of the National Academies of Sciences Related: Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Editorial: Covid-19 has redefined airborne transmission Covid-19: What do we know about airborne transmission of SARS-CoV-2? Real-world data show that filters clean COVID-causing […]
The post Review: SARS-CoV-2 indoor air transmission is a threat that can be addressed with science. appeared first on Links Medicus.
